<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<?OntoDPSData docID="3370589" markupID="2092790" OntoTechnologyVersion="3.59.92.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:BasicEntity="http://www.abbyy.com/ns/BasicEntity#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:Aux="http://www.abbyy.com/ns/Aux#">
	<BasicEntity:MoneySimplified rdf:nodeID="bnode3E8AE41C-12A2-43BB-BACB-48A86F3ECAF0">
		<BasicEntity:ms_major_currency xml:lang="en-US">Euro</BasicEntity:ms_major_currency>
		<BasicEntity:ms_major_amount xml:lang="en-US">8.1</BasicEntity:ms_major_amount>
	</BasicEntity:MoneySimplified>
	<Aux:TextAnnotations rdf:nodeID="bnode2C507734-A362-4A05-A065-C88312C17BD0">
		<Aux:document_text xml:lang="en-US">With coming into force of the GMG, the AMPreisV (AMPriceV) for prescription drugs has been subject to fundamental modification. At the level of the pharmaceutical wholesale trade, the proportional extra charge on the producers' sales price has been approximately halved. Thus the average margin of the wholesale trade on prescription drugs amounts at present only to 6,5 percent. According to information by the Bundesverband des pharmazeutischen Großhandels, PHAGRO (Federal Association of the Pharmaceutical Wholesale Trade) this shortened margin does no longer concede any range for reductions as they had been previously accorded to pharmacists. The legislator has thus implemented his manifested objective to eliminate reductions formerly usual in the system of the sale of pharmaceuticals in favor of the GKV.  At present the pharmacy adds an extra charge of generally only three percent to the reduced wholesale sales price - compared with 30 to 68 percent - as well as a fixed charge of 8,10 Euro and the sales tax. The latter is still at 16 percent and has not been reduced to half of the turnover tax rate - as often requested in the preliminary stages of the GMG adoption. By means of the fixed supplement introduced, the consulting service of the pharmacy when dispensing pharmaceuticals is to be compensated which had not been taken into account in the earlier price formation system.</Aux:document_text>
		<Aux:annotation>
			<Aux:InstanceAnnotation rdf:nodeID="bnode9D45BB77-777F-406E-8B66-BC29A2799EA3">
				<Aux:annotation_start rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">995</Aux:annotation_start>
				<Aux:annotation_end rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1004</Aux:annotation_end>
				<Aux:instance rdf:nodeID="bnode3E8AE41C-12A2-43BB-BACB-48A86F3ECAF0"/>
			</Aux:InstanceAnnotation>
		</Aux:annotation>
		<Aux:annotation>
			<Aux:PropertyAnnotation rdf:nodeID="bnode50C1C7D6-FA99-4FF9-A682-0321A4A60B9D">
				<Aux:annotation_start rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">995</Aux:annotation_start>
				<Aux:annotation_end rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">999</Aux:annotation_end>
				<Aux:instance rdf:nodeID="bnode3E8AE41C-12A2-43BB-BACB-48A86F3ECAF0"/>
				<Aux:property_name xml:lang="en-US">http://www.abbyy.com/ns/BasicEntity#ms_major_amount</Aux:property_name>
				<Aux:property_value xml:lang="en-US">8.1</Aux:property_value>
			</Aux:PropertyAnnotation>
		</Aux:annotation>
		<Aux:annotation>
			<Aux:PropertyAnnotation rdf:nodeID="bnodeD96EAADD-C60F-4AD1-9B84-013A7817264E">
				<Aux:annotation_start rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1000</Aux:annotation_start>
				<Aux:annotation_end rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1004</Aux:annotation_end>
				<Aux:instance rdf:nodeID="bnode3E8AE41C-12A2-43BB-BACB-48A86F3ECAF0"/>
				<Aux:property_name xml:lang="en-US">http://www.abbyy.com/ns/BasicEntity#ms_major_currency</Aux:property_name>
				<Aux:property_value xml:lang="en-US">Euro</Aux:property_value>
			</Aux:PropertyAnnotation>
		</Aux:annotation>
	</Aux:TextAnnotations>
</rdf:RDF>